Anna Shell, RPH in Brownsboro, AL - Pharmacist

Anna Shell, RPH is a Pharmacist based in Brownsboro, Alabama. Anna Shell is licensed to practice in Alabama (license number 13315) and her current practice location is 1030 Dug Hill Rd, Brownsboro, Alabama. She can be reached at her office (for appointments etc.) via phone at (256) 527-8169.

NPI number for Anna Shell is 1184236846 and her current mailing address is 1030 Dug Hill Rd, Brownsboro, Alabama. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1184236846.

Contact Information

	Anna Shell, RPH
	1030 Dug Hill Rd, Brownsboro, AL 35741-9221
	(256) 527-8169
	Not Available

Healthcare Provider's Profile

Full Name	Anna Shell
Gender	Female
Speciality	Pharmacist
Location	1030 Dug Hill Rd, Brownsboro, Alabama
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1184236846
Provider Enumeration Date: 08/23/2020
Last Update Date: 08/23/2020

Medical Identifiers

Medical identifiers for Anna Shell such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1184236846	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	13315 (Alabama)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Anna Shell is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Anna Shell, RPH 1030 Dug Hill Rd, Brownsboro, AL 35741-9221 Ph: (256) 527-8169	Anna Shell, RPH 1030 Dug Hill Rd, Brownsboro, AL 35741-9221 Ph: (256) 527-8169

News Archive

Nearly 1% of all newborns in Switzerland diagnosed with congenital heart defect

Approximately one percent of all newborns in Switzerland are diagnosed with a congenital heart defect, roughly half of them require open heart surgery. Most children, including those with the most severe heart defects, survive because of the significant advancements in surgical techniques. Therefore, the current research focuses less on survival than on long-term consequences and quality of life of these children.

Tumors 'not always greatest mortality risk in RCC patients'

Patients with localized solid kidney tumors may be at greater risk for death from non-cancer-related causes before that from disease progression and cancer-related mortality, say US researchers who developed a comorbidity-based risk prediction model.

Study sheds light on the behavior of 'bystanders' who witness cyberbullying

Cyberbullying is drawing increasing attention, with online activity soaring and a larger number of bullying cases resulting in tragedy. "Bystander Intervention in Cyberbullying" a new study published in the National Communication Association's Communication Monographs reveals specific online conditions under which witnesses to cyberbullying are likely (or unlikely) to intervene in defense of a victim.

Molecule that blocks bone destruction could provide potential therapeutic target for osteoporosis

UT-Southwestern cancer researchers have identified a promising molecule that blocks bone destruction and, therefore, could provide a potential therapeutic target for osteoporosis and bone metastases of cancer.

Researchers caution pregnant women about eating red and processed meats

Pregnant women and women planning to become pregnant can make use of the holiday season to adjust their diets and reduce the risk of gestational diabetes, according to researchers at the University of Adelaide's Robinson Institute.

Anna Shell, RPH - Pharmacist in Brownsboro, AL